Could high TPO antibodies indicate Hashimoto's or Graves' disease?

High TPO antibodies most commonly indicate Hashimoto's thyroiditis, though they can also appear in Graves' disease and other thyroid conditions. Testing TPO antibodies alongside TSH, Free T4, and Free T3 helps determine the specific thyroid disorder and guide treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding TPO antibodies and thyroid health

Thyroid peroxidase (TPO) antibodies are autoimmune markers that attack an enzyme crucial for thyroid hormone production. When your immune system mistakenly targets thyroid peroxidase—an enzyme that helps produce thyroid hormones T3 and T4—it creates these antibodies. Finding elevated TPO antibodies in your blood work often signals an autoimmune thyroid condition, with Hashimoto's thyroiditis being the most common culprit.

The presence of TPO antibodies indicates your immune system is attacking your thyroid gland, but the antibody levels alone cannot definitively diagnose whether you have Hashimoto's or Graves' disease. Both conditions involve thyroid autoimmunity, but they affect thyroid function in opposite ways—Hashimoto's typically leads to an underactive thyroid (hypothyroidism), while Graves' disease causes an overactive thyroid (hyperthyroidism).

What are normal and elevated TPO antibody levels?

TPO antibody levels are measured in international units per milliliter (IU/mL), and reference ranges can vary slightly between laboratories. Understanding these ranges helps contextualize your test results and their clinical significance.

TPO Antibody Reference Ranges and Clinical Significance

TPO Antibody LevelInterpretationClinical SignificanceFollow-up Recommended
<35 IU/mL<35 IU/mLNormalNo thyroid autoimmunity detectedRoutine screening only
35-100 IU/mL35-100 IU/mLMildly ElevatedPossible early autoimmune activityAnnual thyroid function tests
100-500 IU/mL100-500 IU/mLModerately ElevatedActive thyroid autoimmunity likelyTest every 6 months, monitor symptoms
>500 IU/mL>500 IU/mLSignificantly ElevatedStrong indication of Hashimoto's or other thyroid diseaseComprehensive thyroid panel, possible treatment

Reference ranges may vary by laboratory. Always interpret results in context with thyroid function tests and clinical symptoms.

Generally, TPO antibody levels below 35 IU/mL are considered normal, though some labs use a cutoff of 9 IU/mL. Levels above the reference range indicate the presence of thyroid autoimmunity. The higher the antibody level, the more aggressive the autoimmune attack on your thyroid gland. However, antibody levels can fluctuate over time and don't always correlate directly with symptom severity.

Interpreting your TPO antibody results

While any elevation above the normal range is significant, extremely high levels (often above 500 IU/mL) suggest more active autoimmune thyroid disease. Some people with Hashimoto's thyroiditis have TPO antibody levels in the thousands. It's important to note that about 10-15% of healthy individuals may have slightly elevated TPO antibodies without developing thyroid disease, particularly as they age.

TPO antibodies in Hashimoto's thyroiditis

Hashimoto's thyroiditis is the most common cause of elevated TPO antibodies, with approximately 90-95% of people with Hashimoto's testing positive for these antibodies. In this condition, the immune system gradually destroys thyroid tissue, leading to decreased thyroid hormone production and eventual hypothyroidism.

The autoimmune attack in Hashimoto's is typically slow and progressive. Early in the disease, your thyroid may still produce normal amounts of hormones despite the presence of TPO antibodies. As the condition progresses, thyroid function declines, and TSH levels rise as your pituitary gland tries to stimulate more thyroid hormone production. Regular monitoring through comprehensive thyroid panels can help track this progression and guide treatment decisions.

Symptoms associated with Hashimoto's

People with Hashimoto's thyroiditis often experience symptoms of hypothyroidism as their thyroid function declines:

  • Persistent fatigue and weakness
  • Weight gain despite no change in diet
  • Cold intolerance
  • Dry skin and hair loss
  • Constipation
  • Depression and brain fog
  • Muscle aches and joint pain
  • Irregular menstrual periods in women

TPO antibodies in Graves' disease

While TPO antibodies are more strongly associated with Hashimoto's, they're also present in about 70-80% of people with Graves' disease. However, Graves' disease has its own specific antibody marker—thyroid-stimulating immunoglobulin (TSI) or TSH receptor antibodies (TRAb)—that directly stimulate the thyroid to produce excess hormones.

In Graves' disease, the presence of TPO antibodies indicates a broader autoimmune attack on the thyroid. These patients often have multiple thyroid antibodies present, reflecting the complex nature of thyroid autoimmunity. The key difference is that Graves' disease causes hyperthyroidism, with symptoms opposite to those seen in Hashimoto's.

Distinguishing features of Graves' disease

Graves' disease presents with hyperthyroid symptoms including:

  • Rapid heartbeat and palpitations
  • Unexplained weight loss
  • Heat intolerance and excessive sweating
  • Tremors in hands
  • Anxiety and irritability
  • Bulging eyes (Graves' ophthalmopathy)
  • Frequent bowel movements
  • Muscle weakness

Other conditions associated with elevated TPO antibodies

Beyond Hashimoto's and Graves' disease, elevated TPO antibodies can appear in several other conditions. Understanding these associations helps provide context for your test results and guides further evaluation.

Postpartum thyroiditis

About 5-10% of women develop postpartum thyroiditis within the first year after giving birth. Women with positive TPO antibodies during pregnancy have a significantly higher risk of developing this condition. Postpartum thyroiditis typically causes a period of mild hyperthyroidism followed by hypothyroidism, though many women eventually recover normal thyroid function.

Other autoimmune conditions

TPO antibodies may also be elevated in people with other autoimmune conditions, even without clinical thyroid disease. These include:

  • Type 1 diabetes
  • Rheumatoid arthritis
  • Lupus
  • Sjögren's syndrome
  • Celiac disease
  • Pernicious anemia

Comprehensive thyroid testing beyond TPO antibodies

While TPO antibodies provide valuable information about thyroid autoimmunity, they're just one piece of the puzzle. A complete thyroid evaluation should include multiple biomarkers to accurately diagnose and monitor thyroid conditions.

Essential thyroid tests include TSH (thyroid-stimulating hormone), Free T4, and Free T3. TSH is often the first test ordered, as it sensitively reflects thyroid function—high TSH suggests hypothyroidism (as in Hashimoto's), while low TSH indicates hyperthyroidism (as in Graves'). Free T4 and Free T3 measure the actual thyroid hormones available to your tissues.

For suspected Graves' disease, testing should also include TSH receptor antibodies (TRAb) or thyroid-stimulating immunoglobulin (TSI). These antibodies are more specific to Graves' disease and help differentiate it from other causes of hyperthyroidism. Some people may also benefit from testing thyroglobulin antibodies (TgAb), another marker of thyroid autoimmunity often elevated alongside TPO antibodies.

Treatment approaches for elevated TPO antibodies

Treatment for elevated TPO antibodies depends on whether you have thyroid dysfunction and which specific condition is present. Not everyone with positive TPO antibodies requires immediate treatment—some people maintain normal thyroid function despite having antibodies.

Managing Hashimoto's thyroiditis

For Hashimoto's with hypothyroidism, the standard treatment is thyroid hormone replacement therapy, typically with levothyroxine (synthetic T4). The goal is to normalize TSH levels and alleviate symptoms. Some patients benefit from combination therapy with both T4 and T3, though this remains controversial. Regular monitoring ensures optimal dosing, as requirements can change over time.

Lifestyle modifications can also support thyroid health in Hashimoto's. These include maintaining adequate selenium and vitamin D levels, managing stress, ensuring sufficient sleep, and following an anti-inflammatory diet. Some people find that avoiding gluten helps reduce antibody levels, particularly if they have concurrent celiac disease.

Treating Graves' disease

Graves' disease treatment aims to reduce thyroid hormone production and manage symptoms. Options include:

  • Antithyroid medications (methimazole or propylthiouracil)
  • Radioactive iodine therapy to reduce thyroid tissue
  • Thyroid surgery (thyroidectomy) in severe cases
  • Beta-blockers for symptom management

The choice of treatment depends on factors like age, pregnancy status, goiter size, and patient preference. Many patients eventually develop hypothyroidism after treatment and require lifelong thyroid hormone replacement.

Monitoring and long-term management

If you have elevated TPO antibodies, regular monitoring is essential, even if your thyroid function is currently normal. Studies show that people with positive TPO antibodies have a higher risk of developing overt thyroid dysfunction over time. Annual testing of TSH and Free T4 can catch changes early, allowing for prompt treatment if needed.

For those already on treatment, monitoring frequency depends on stability. Newly diagnosed patients or those with dose adjustments may need testing every 6-8 weeks until stable. Once stabilized, testing every 6-12 months is typically sufficient. Comprehensive testing that includes all relevant thyroid markers provides the most complete picture of your thyroid health and treatment effectiveness.

Lifestyle factors that may influence antibody levels

While you cannot completely eliminate thyroid antibodies once present, certain lifestyle factors may help reduce levels and support overall thyroid health:

  • Stress management through meditation, yoga, or counseling
  • Regular exercise (but avoiding overtraining)
  • Adequate sleep (7-9 hours nightly)
  • Anti-inflammatory diet rich in whole foods
  • Avoiding environmental toxins when possible
  • Maintaining optimal vitamin D and selenium levels
  • Managing gut health through probiotics and fiber

The importance of early detection and comprehensive testing

Early detection of thyroid autoimmunity through TPO antibody testing can lead to better outcomes. Even if your thyroid function is normal now, knowing you have positive antibodies allows for closer monitoring and earlier intervention if dysfunction develops. This is particularly important for women planning pregnancy, as thyroid dysfunction can affect fertility and fetal development.

Comprehensive thyroid testing that goes beyond just TSH provides crucial insights into your thyroid health. Including TPO antibodies, Free T4, and Free T3 in your testing panel ensures you won't miss subclinical thyroid dysfunction or autoimmune activity. This complete picture enables personalized treatment decisions and better long-term health outcomes.

References

  1. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-499.[PubMed][DOI]
  2. McLeod DS, Cooper DS. The incidence and prevalence of thyroid autoimmunity. Endocrine. 2012;42(2):252-265.[PubMed][DOI]
  3. Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Engl J Med. 2003;348(26):2646-2655.[PubMed][DOI]
  4. Vanderpump MP, Tunbridge WM, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68.[PubMed][DOI]
  5. Smith TJ, Hegedüs L. Graves' Disease. N Engl J Med. 2016;375(16):1552-1565.[PubMed][DOI]
  6. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my TPO antibodies at home?

You can test your TPO antibodies at home with SiPhox Health's Core Health Program by adding the Thyroid+ expansion, which includes TPOAb, Free T3, and Free T4 testing along with the base TSH test. This CLIA-certified program provides comprehensive thyroid testing from the comfort of your home.

What's the difference between TPO antibodies in Hashimoto's vs Graves' disease?

While TPO antibodies can be elevated in both conditions, they're found in 90-95% of Hashimoto's cases versus 70-80% of Graves' cases. The key difference is that Hashimoto's causes hypothyroidism while Graves' causes hyperthyroidism. Graves' disease also has specific antibodies (TSI/TRAb) that directly stimulate the thyroid.

Can TPO antibodies go away on their own?

TPO antibodies typically don't disappear completely once present, but levels can fluctuate and sometimes decrease with treatment and lifestyle modifications. Some people maintain normal thyroid function despite having antibodies, while others may see antibody levels reduce with interventions like selenium supplementation or dietary changes.

Should I get treated if I have high TPO antibodies but normal thyroid function?

Treatment isn't always necessary if your thyroid function (TSH, Free T4, Free T3) is normal despite elevated TPO antibodies. However, you should have regular monitoring every 6-12 months as you're at higher risk for developing thyroid dysfunction. Some doctors may recommend selenium supplementation or lifestyle modifications to support thyroid health.

What other tests should I get if my TPO antibodies are high?

If your TPO antibodies are elevated, you should get a complete thyroid panel including TSH, Free T4, and Free T3. If hyperthyroidism is suspected, add TSH receptor antibodies (TRAb/TSI). Consider testing thyroglobulin antibodies (TgAb) as they're often elevated alongside TPO antibodies. Thyroid ultrasound may also be recommended to assess gland structure.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details